| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/18/2002 | WO2002031508A1 Methods for detecting modulators of ion channels using thallium (i) sensitive assays |
| 04/18/2002 | WO2002031507A2 Non-invasive enzyme screen for tissue remodelling-associated conditions |
| 04/18/2002 | WO2002031506A1 Compositions and methods for separation of moieties on chips |
| 04/18/2002 | WO2002031504A1 An analyte detection system |
| 04/18/2002 | WO2002031503A1 Assay method and kit therefor |
| 04/18/2002 | WO2002031500A2 Method for diagnosing or classifying carcinomas, based on the detection of igf-ir$g(b) and irs-1 |
| 04/18/2002 | WO2002031499A1 Detection of neurodegenerative disorders |
| 04/18/2002 | WO2002031498A2 Protecting therapeutic compositions from host-mediated inactivation |
| 04/18/2002 | WO2002031497A1 Means of examining ability of angiogenesis |
| 04/18/2002 | WO2002031496A2 Device for determining skin aging in vitro |
| 04/18/2002 | WO2002031495A1 Electron paramagnetic resonance method for diagnosis of active nephritis |
| 04/18/2002 | WO2002031494A1 Ball impact assembly for inspecting the quality of concrete structure |
| 04/18/2002 | WO2002031493A1 Method of treating metal analysis sample and device thereof |
| 04/18/2002 | WO2002031491A2 Apparatus and methods for affinity capture tandem mass spectrometry |
| 04/18/2002 | WO2002031488A1 Co2 sensor |
| 04/18/2002 | WO2002031487A2 Ultrasonic austenitic weld seam inspection method and apparatus |
| 04/18/2002 | WO2002031486A1 Method and device for the on-board diagnosis of an nox sensor |
| 04/18/2002 | WO2002031485A1 Acid gas measuring sensors and method of making same |
| 04/18/2002 | WO2002031484A2 Methods for characterizing molecular interactions using affinity capture tandem mass spectrometry |
| 04/18/2002 | WO2002031482A2 Device and method for electrically accelerated immobilisation of molecules |
| 04/18/2002 | WO2002031481A2 Device and method for electrically accelerated immobilisation and detection of molecules |
| 04/18/2002 | WO2002031478A2 Methods and devices for assays using analyte-binding partners |
| 04/18/2002 | WO2002031477A2 Fiber optic apparatus and use thereof in combinatorial material science |
| 04/18/2002 | WO2002031476A2 Methods and apparatus for downhole fluids analysis |
| 04/18/2002 | WO2002031469A1 Exhaust gas particulate mass measurement apparatus with real-time moisture monitor |
| 04/18/2002 | WO2002031466A1 Method for performing chemical and isotopic analysis and measurements on constituents transported by a bore fluid |
| 04/18/2002 | WO2002031464A2 Evaluating binding affinities by force stratification and force planning |
| 04/18/2002 | WO2002031463A2 High density column and row addressable electrode arrays |
| 04/18/2002 | WO2002031207A1 Method and apparatus for the in-situ preparation of macromolecules via uniform glow discharge plasma |
| 04/18/2002 | WO2002031203A2 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 04/18/2002 | WO2002031201A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/18/2002 | WO2002031198A2 Cancer-linked genes as targets for chemotherapy |
| 04/18/2002 | WO2002031197A1 Method for identifying increased risk of death from community acquired pneumonia |
| 04/18/2002 | WO2002031193A1 Method of analyzing nucleic acid |
| 04/18/2002 | WO2002031192A1 Method of constructing self-assembly of probes and method of detecting the same |
| 04/18/2002 | WO2002031191A2 Dendritically amplified detection method |
| 04/18/2002 | WO2002031188A2 Method and device for predicting haplotypes |
| 04/18/2002 | WO2002031186A2 Method for the detection of cytosine methylations |
| 04/18/2002 | WO2002031185A1 Method of identifying abnormal immune reactions |
| 04/18/2002 | WO2002031183A1 Nanoscale sensor |
| 04/18/2002 | WO2002031182A2 Method and apparatus for reading reporter labeled beads |
| 04/18/2002 | WO2002031179A2 Multiplex assays using nanoparticles |
| 04/18/2002 | WO2002031151A2 Lipocalins |
| 04/18/2002 | WO2002031146A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | WO2002031144A2 Identification of cytotoxic activity from the ink of aplysia punctata |
| 04/18/2002 | WO2002031134A2 Novel serine protease genes related to dppiv |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002031025A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/18/2002 | WO2002030987A1 Antihuman heme oxygenase-1 monoclonal antibody |
| 04/18/2002 | WO2002030981A1 Gene encoding a human g-protein coupled receptor and its use |
| 04/18/2002 | WO2002030980A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 04/18/2002 | WO2002030967A2 Novel compounds |
| 04/18/2002 | WO2002030964A2 Comparative ligand mapping from mhc positive cells |
| 04/18/2002 | WO2002030963A1 Human ect2 and methods of use |
| 04/18/2002 | WO2002030946A1 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods |
| 04/18/2002 | WO2002030944A2 Fluorescent nucleobase conjugates having anionic linkers |
| 04/18/2002 | WO2002030937A2 Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay |
| 04/18/2002 | WO2002030868A1 Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| 04/18/2002 | WO2002030595A1 Process for producing, through strip casting, raw alloy for nanocomposite type permanent magnet |
| 04/18/2002 | WO2002030571A2 Surface adsorbing polymers and the uses thereof to treat hydrophobic or hydrophilic surfaces |
| 04/18/2002 | WO2002030562A1 An integrated biochip system for sample preparation and analysis |
| 04/18/2002 | WO2002030478A2 Detection of the presence of a microbe or related substance at a location |
| 04/18/2002 | WO2002030462A2 Hedgehog antagonists, methods and uses related thereto |
| 04/18/2002 | WO2002030454A1 Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype |
| 04/18/2002 | WO2002030429A1 Combination therapy for the treatment of estrogen-sensitive disease |
| 04/18/2002 | WO2002030391A2 Method for determining the release of a peptide from a sustained release polylactide formulation |
| 04/18/2002 | WO2002030275A1 Optical sensor for in situ measurement of analytes |
| 04/18/2002 | WO2002030268A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | WO2002030266A2 Detection of dna damage |
| 04/18/2002 | WO2002030265A2 Method and display for multivariate classification |
| 04/18/2002 | WO2002030256A2 Diagnostic indicator of thymic function |
| 04/18/2002 | WO2002030185A1 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same |
| 04/18/2002 | WO2002014499A9 Claudin polypeptides |
| 04/18/2002 | WO2002012879A3 Method of diagnosing colorectal adenomas and cancer using proton magnetic resonance spectroscopy |
| 04/18/2002 | WO2002011606A3 Diagnostic tests for anti-endotoxin core antibodies |
| 04/18/2002 | WO2002010747A3 Method and apparatus for patch-clamp measurements on cells |
| 04/18/2002 | WO2002008760A8 Method of identifying cancer markers and uses therefor in the diagnosis of cancer |
| 04/18/2002 | WO2002008753A3 Device for measuring analyte concentration in a fluid |
| 04/18/2002 | WO2002008272A3 High affinity soluble interleukin-18 receptor |
| 04/18/2002 | WO2002008252A3 Novel protein containing ring finger domaine r1p4 |
| 04/18/2002 | WO2002006478A3 Extracellular matrix protein |
| 04/18/2002 | WO2002006314A3 Peptides and their use in assays for cardiovascular disease |
| 04/18/2002 | WO2002004950A3 Direct assessment of analyte to reference molecule ratios |
| 04/18/2002 | WO2002004596A3 Diagnosing and treating cancer cells using mutant viruses |
| 04/18/2002 | WO2002003921A3 Bax fragment induced tumor cell death |
| 04/18/2002 | WO2002003919A3 Structural targets in hepatitis c virus ires element |
| 04/18/2002 | WO2002003056A8 Method for the analysis of a selected multicomponent sample |
| 04/18/2002 | WO2002002488A3 Methods and compounds for modulating nuclear receptor coactivator binding |
| 04/18/2002 | WO2002001949A3 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof |
| 04/18/2002 | WO2001094943A3 Method for determining the quantity of ligands that are bound to target molecules |
| 04/18/2002 | WO2001094921A3 A ph sensor system and method for using same |
| 04/18/2002 | WO2001090741A3 Emission sampling apparatus and method |
| 04/18/2002 | WO2001089692A3 Nucleic acid amplification and detection using microfluidic diffusion based structures |
| 04/18/2002 | WO2001085954A3 Serine-threonine kinase-3 |
| 04/18/2002 | WO2001085766A3 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders |
| 04/18/2002 | WO2001083744A3 Natrium-calcium exchanger protein |
| 04/18/2002 | WO2001082958A3 Methods of producing membrane vesicles |
| 04/18/2002 | WO2001081574A3 Regulation of nf-at interacting protein nip 45 variant |
| 04/18/2002 | WO2001081409A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |